Alembic Pharmaceuticals Limited (NSEI: APLLTD)
Health Care · Pharmaceuticals · IN
Rs800.95
-1.75% today · -15.1% 1Y
Alembic Pharmaceuticals Limited (NSEI: APLLTD) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.63B and employs 17,244 people.
Over the last twelve months the share price has lost 15.1%, trading between 635.80 and 998.00.
Tweenvest scores Alembic Pharmaceuticals Limited across four factors: quality 76/100, value 61/100, growth 53/100, dividend 48/100. Its strongest factor is quality.
APLLTD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.63B
- Revenue (TTM)
- $823.25M
- P/E
- 22.70
- EPS
- 35.28
- Dividend yield
- 1.50%
- Beta (5Y)
- 0.32
- 52-week high
- Rs998.00
- 52-week low
- Rs635.80
- Avg volume (3M)
- —
- Shares outstanding
- 196.56M
- Employees
- 17,244
- Next earnings
- —
About Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited is a pharmaceutical firm that develops, manufactures, and markets medicinal products both domestically in India and across international markets. Its offerings encompass active pharmaceutical ingredients (APIs) and a wide array of formulations. The company provides both proprietary (branded) and generic medications, addressing numerous therapeutic needs such as cardiovascular health, women's health, gastrointestinal issues, eye and skin conditions, kidney/urinary tract disorders, orthopedic ailments, anti-infective treatments, remedies for cold and cough, and anti-diabetic management. Furthermore, the company engages in the export of its diverse product portfolio. Founded in 1907, Alembic Pharmaceuticals Limited maintains its main office in Vadodara, India.
- ISIN
- INE901L01018
- Founded
- 1907
- Listed since
- Sep 20, 2011
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Henan Lingrui Pharmaceutical Co., Ltd.SHSE: 600285 | $1.66B | CN¥19.66 | +3.04% |
| Hanall Biopharma Co., Ltd.KOSE: A009420 | $1.66B | ₩44,000.00 | -4.56% |
| Ocular Therapeutix, Inc.NasdaqGM: OCUL | $1.66B | $7.58 | +0.46% |
| Tibet Cheezheng Tibetan Medicine Co., Ltd.SZSE: 002287 | $1.66B | CN¥19.56 | +0.93% |
| Shenzhen Chipscreen Biosciences Co., Ltd.SHSE: 688321 | $1.61B | CN¥24.31 | -3.61% |
| Inner Mongolia Furui Medical Science Co., Ltd.SZSE: 300049 | $1.60B | CN¥40.49 | -14.05% |
| Consun Pharmaceutical Group LimitedSEHK: 1681 | $1.59B | HK$14.85 | +0.81% |
| ANI Pharmaceuticals, Inc.NasdaqGM: ANIP | $1.58B | $73.79 | -0.14% |
Figures last refreshed Oct 11, 2026.